Barinthus Biotherapeutics plc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Barinthus Biotherapeutics plc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q1 2021 to Q2 2024.
  • Barinthus Biotherapeutics plc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending June 30, 2024 was $1.93M, a 8.19% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.93M +$146K +8.19% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.93M +$174K +9.93% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.79M Dec 31, 2023 10-K 2024-03-20
Q3 2023 $1.74M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.78M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.75M +$1.28M +271% Mar 31, 2023 10-Q 2023-05-12
Q1 2022 $472K +$148K +45.7% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $599K Dec 31, 2021 10-K 2022-03-25
Q3 2021 $615K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $324K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $324K Mar 31, 2021 10-Q 2021-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.